MGTX peer analysis
MeiraGTx (MGTX) against its competitors: price, today's move, 1-year return and market value side by side.
MGTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| FDMT 4D Molecular | $12.11 | -6.81% | 20.28% | $717.62M |
| KRYS Krystal Biotech | $305.88 | -0.95% | 52.12% | $9.15B |
| LCTX Lineage Cell Therapeutics | $0.99 | -10.80% | -39.01% | $280.73M |
| NTLA Intellia | $10.64 | -6.75% | 10.81% | $1.58B |
| OCGN Ocugen | $0.88 | -8.78% | -27.95% | $325.12M |
| PASG Passage Bio | $4.00 | 5.82% | -48.05% | $12.87M |
| QURE uniQure | $24.62 | 0.14% | -20.28% | $1.72B |
| RGNX REGENXBIO | $8.04 | -5.08% | -26.67% | $559.13M |
| SANA Sana | $2.03 | -11.35% | -45.99% | $686.16M |
| MGTX MeiraGTx | $8.78 | -9.35% | 6.63% | $911.45M |
- MGTX's peers: FDMT (4D Molecular), KRYS (Krystal Biotech), LCTX (Lineage Cell Therapeutics), NTLA (Intellia), OCGN (Ocugen), PASG (Passage Bio), QURE (uniQure), RGNX (REGENXBIO).
Updated 2026-11-13 04:50 UTC